Cochlear

Cochlear develops implantable hearing solutions, chiefly cochlear implants and bone conduction devices, for people with severe to profound hearing loss. The company describes itself as the world's leading implantable hearing solutions business and reports that its devices have been used by more than 700,000 recipients across over 180 countries.

The company operates in the medical devices and healthcare sectors, with technical work spanning cochlear implant technology, bone conduction technology, biomedical engineering and auditory prosthetics. It employs more than 4,000 people in over 30 countries and invests over AUD$180 million a year in research and development, holding more than 100 patent families.

Products fall into two main lines: cochlear implants, which restore hearing in cases of severe to profound loss, and bone conduction devices, which transmit sound through bone. Cochlear's origins trace to the work of Professor Graeme Clark, and the company states that its implants are chosen more often than those of any other hearing implant company.